Crinetics Approach

Crinetics Presents New Posters on ACTH Antagonist and SST5 Agonist Programs at ENDO Online 2020

Crinetics Presents New Posters on ACTH Antagonist and SST5 Agonist Programs at ENDO Online 2020

Discovery and Identification of Late Stage, Selective Nonpeptide ACTH Antagonists for the Treatment
of Cushing’s Disease, Ectopic ACTH Secreting Tumors, and Congenital Adrenal Hyperplasia

Ana K. Kusnetzow, Sangdon Han, Melissa A. Fowler, Jon Athanacio, Greg Reinhart, Elizabeth Rico-Bautista, Sun Hee Kim, Michael Johns, Taylor A. Kredel, Agnes Antwan, Oleg Tsivkovski, Julie Nguyen, Christine Staley, Hannah Tan, Rosalia de Necochea-Campion, Jacob Hawver Pachter, Rosa Luo, Stacy Markison, Ajay Madan, Yun Fei Zhu, R. Scott Struthers, Stephen F. Betz. ENDO Online 2020. June 8-22, 2020.

Discovery and Identification of Late Stage, Selective Nonpeptide Somatostatin Subtype 5 (SST5)
Agonists for the Treatment of Hyperinsulinemic Hypoglycemia

Melissa A. Fowler, Jian Zhao, Emmanuel Sturchler, Elizabeth Rico-Bautista, Rosalia de Necochea-Campion, Jon Athanacio, Taylor A. Kredel, Agnes Antwan, Michael Johns, Oleg Tsivkoski, Shimiao Wang, Rosa Luo, Ana K. Kusnetzow, Ajay Madan, R. Scott Struthers, Stacy Markison, Yun Fei Zhu, Stephen F. Betz. ENDO Online 2020. June 8-22, 2020.